Blog

Insights on account research, sales intelligence, and B2B selling from the Salesmotion team.

AllABMAccount ResearchCompany NewsCompany UpdateComparisonsIndustry InsightsIndustry NewsNewsOutboundProductProduct UpdateRevOpsSalesStrategyToolsTutorials
Clarivate Alternatives for Life Sciences: What to Evaluate in 2026
Industry News

Clarivate Alternatives for Life Sciences: What to Evaluate in 2026

Clarivate has agreed to sell its LS&HC division to Altaris. Life sciences teams need a clear alternatives map — here is how to evaluate replacements by use case: R&D, commercial, and BD.

Semir Jahic··14 min read
Clarivate Is Selling Its Life Sciences Business — What It Means for Sales Teams
Industry News

Clarivate Is Selling Its Life Sciences Business — What It Means for Sales Teams

Clarivate has agreed to sell its $390M Life Sciences & Healthcare division to Altaris for $600M. What this means for pharma and CRO sales teams, and why GenAI-native platforms are gaining ground.

Semir Jahic··10 min read